| PE21.01 | gp120-mediated CD4+ T cell activation is inhibited by non-neutralizing V2 loop antibodies | E-poster | Novel vaccine and other prevention approaches |
| PE20.08 | The impact of human immunodeficiency virus-1 viral replicative capacity on infection of human cervical and rectal tissue explants ex vivo | E-poster | Mucosal immunity |
| PE20.07 | Effects of continued Progestin-based contraceptive usage in the adolescent genital tract: implications for HIV acquisition | E-poster | Mucosal immunity |
| PE20.06 | Acute sexual violence exposure dysregulates HIV associated cervical immune biomarkers in women | E-poster | Mucosal immunity |
| PE20.05 | Impact of gender affirmation surgery and exogenous hormones on mucosal immune responses and risk of HIV transmission in transgender women | E-poster | Mucosal immunity |
| PE20.04 | The impact of TGF-β on the genital immune environment associated with HIV risk in young women | E-poster | Mucosal immunity |
| PE20.03 | Mucosal responses to HIV-1 co-infection with an emerging pathogen, Zika virus | E-poster | Mucosal immunity |
| PE20.02 | The effect of HPV-associated anal dysplasia on HIV susceptibility in men who have sex with men | E-poster | Microbiome & STI: impact on prevention |
| PE20.01 | The Impact of Progestin-based Contraceptive Initiation on the Cervicovaginal Proteome in participants from the ECHO trial | E-poster | Microbiome & STI: impact on prevention |
| PE19.09LB | Experimental microbial dysbiosis enhances rectal SIV acquisition in male rhesus macaques | E-poster | Microbiome & STI: impact on prevention |